AAAAAA

   
Results: 1-12 |
Results: 12
DETERMINATION OF NIFEDIPINE IN HUMAN PLASMA BY FLOW-INJECTION TANDEM MASS-SPECTROMETRY
Authors: DANKERS J VANDENELSHOUT J AHR G BRENDEL E VANDERHEIDEN C
Citation: J. Dankers et al., DETERMINATION OF NIFEDIPINE IN HUMAN PLASMA BY FLOW-INJECTION TANDEM MASS-SPECTROMETRY, Journal of chromatography B. Biomedical sciences and applications, 710(1-2), 1998, pp. 115-120
INTERETHNIC COMPARISONS OF THE PHARMACOKINETICS OF THE HMG-COA REDUCTASE INHIBITOR CERIVASTATIN
Authors: MUCK W UNGER S KAWANO K AHR G
Citation: W. Muck et al., INTERETHNIC COMPARISONS OF THE PHARMACOKINETICS OF THE HMG-COA REDUCTASE INHIBITOR CERIVASTATIN, British journal of clinical pharmacology, 45(6), 1998, pp. 583-590
PHARMACOKINETICS OF THE CONTROLLED-RELEASE NISOLDIPINE COAT-CORE TABLET FORMULATION
Authors: HEINIG R AHR G HAYAUCHI Y KUHLMANN J
Citation: R. Heinig et al., PHARMACOKINETICS OF THE CONTROLLED-RELEASE NISOLDIPINE COAT-CORE TABLET FORMULATION, International journal of clinical pharmacology and therapeutics, 35(8), 1997, pp. 341-351
ABSOLUTE AND RELATIVE BIOAVAILABILITY OF THE HMG-COA REDUCTASE INHIBITOR CERIVASTATIN
Authors: MUCK W RITTER W OCHMANN K UNGER S AHR G WINGENDER W KUHLMANN J
Citation: W. Muck et al., ABSOLUTE AND RELATIVE BIOAVAILABILITY OF THE HMG-COA REDUCTASE INHIBITOR CERIVASTATIN, International journal of clinical pharmacology and therapeutics, 35(6), 1997, pp. 255-260
PHARMACOKINETIC-PHARMACODYNAMIC MODELING AS A TOOL TO EVALUATE THE CLINICAL RELEVANCE OF A DRUG-FOOD INTERACTION FOR A NISOLDIPINE CONTROLLED-RELEASE DOSAGE FORM
Authors: SCHAEFER HG HEINIG R AHR G ADELMANN H TETZLOFF W KUHLMANN J
Citation: Hg. Schaefer et al., PHARMACOKINETIC-PHARMACODYNAMIC MODELING AS A TOOL TO EVALUATE THE CLINICAL RELEVANCE OF A DRUG-FOOD INTERACTION FOR A NISOLDIPINE CONTROLLED-RELEASE DOSAGE FORM, European Journal of Clinical Pharmacology, 51(6), 1997, pp. 473-480
USE OF SENSITIVE LC-MS MS BIOANALYTICS TO DETERMINE THE EXPOSURE OF THE AZOLE ANTIMYCOTIC DRUG BIFONAZOLE FOLLOWING TOPIC ADMINISTRATION/
Authors: MUCK W ROHDE G SCHUHLY U AHR G
Citation: W. Muck et al., USE OF SENSITIVE LC-MS MS BIOANALYTICS TO DETERMINE THE EXPOSURE OF THE AZOLE ANTIMYCOTIC DRUG BIFONAZOLE FOLLOWING TOPIC ADMINISTRATION/, Naunyn-Schmiedeberg's archives of pharmacology, 355(4), 1997, pp. 489-489
NO INTERETHNIC DIFFERENCES IN STEREOSELECTIVE DISPOSITION OF ORAL NIMODIPINE BETWEEN CAUCASIAN AND JAPANESE SUBJECTS
Authors: MUCK W TANAKA T AHR G KUHLMANN J
Citation: W. Muck et al., NO INTERETHNIC DIFFERENCES IN STEREOSELECTIVE DISPOSITION OF ORAL NIMODIPINE BETWEEN CAUCASIAN AND JAPANESE SUBJECTS, International journal of clinical pharmacology and therapeutics, 34(4), 1996, pp. 163-171
INVESTIGATION OF NIFEDIPINE ABSORPTION IN DIFFERENT REGIONS OF THE HUMAN GASTROINTESTINAL (GI) TRACT AFTER SIMULTANEOUS ADMINISTRATION OF C-13-NIFEDIPINE AND C-12-NIFEDIPINE
Authors: BODE H BRENDEL E AHR G FUHR U HARDER S STAIB AH
Citation: H. Bode et al., INVESTIGATION OF NIFEDIPINE ABSORPTION IN DIFFERENT REGIONS OF THE HUMAN GASTROINTESTINAL (GI) TRACT AFTER SIMULTANEOUS ADMINISTRATION OF C-13-NIFEDIPINE AND C-12-NIFEDIPINE, European Journal of Clinical Pharmacology, 50(3), 1996, pp. 195-201
NIMODIPINE - POTENTIAL FOR DRUG-DRUG INTERACTIONS IN THE ELDERLY
Authors: MUCK W AHR G KUHLMANN J
Citation: W. Muck et al., NIMODIPINE - POTENTIAL FOR DRUG-DRUG INTERACTIONS IN THE ELDERLY, Drugs & aging, 6(3), 1995, pp. 229-242
PHARMACOKINETIC DEVELOPMENT OF QUINOLONE ANTIBIOTICS
Authors: SCHAEFER HG AHR G KUHLMANN J
Citation: Hg. Schaefer et al., PHARMACOKINETIC DEVELOPMENT OF QUINOLONE ANTIBIOTICS, International journal of clinical pharmacology and therapeutics, 33(5), 1995, pp. 266-276
THE EFFECT OF MULTIPLE ORAL DOSING OF NIMODIPINE ON GLIBENCLAMIDE PHARMACODYNAMICS AND PHARMACOKINETICS IN ELDERLY PATIENTS WITH TYPE-2 DIABETES-MELLITUS
Authors: MUCK W HEINE PR BREUEL HP NIKLAUS H HORKULAK J AHR G
Citation: W. Muck et al., THE EFFECT OF MULTIPLE ORAL DOSING OF NIMODIPINE ON GLIBENCLAMIDE PHARMACODYNAMICS AND PHARMACOKINETICS IN ELDERLY PATIENTS WITH TYPE-2 DIABETES-MELLITUS, International journal of clinical pharmacology and therapeutics, 33(2), 1995, pp. 89-94
DETERMINATION OF THE ENANTIOMERS OF NISOLDIPINE IN HUMAN PLASMA USINGHIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY ON A CHIRAL STATIONARY-PHASE AND GAS-CHROMATOGRAPHY WITH MASS-SELECTIVE DETECTION
Authors: HEINIG R MUSCHALEK V AHR G
Citation: R. Heinig et al., DETERMINATION OF THE ENANTIOMERS OF NISOLDIPINE IN HUMAN PLASMA USINGHIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY ON A CHIRAL STATIONARY-PHASE AND GAS-CHROMATOGRAPHY WITH MASS-SELECTIVE DETECTION, Journal of chromatography B. Biomedical applications, 655(2), 1994, pp. 286-292
Risultati: 1-12 |